Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw‐scaled) snake venom

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Toxicon

• Publication date

  2017-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.toxicon.2017.04.001PMID 28400263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Toxicology of Snakebite In Africa and The Middle East / Arabian Peninsula

  2017influential reference
• Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation

  2016cited by this paper
• Natural Inhibitors of Snake Venom Metalloendopeptidases: History and Current Challenges

  2016cited by this paper
• From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.

  2016cited by this paper
• The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay.

  2015cited by this paper
• A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.

  2014cited by this paper
• Public health aspects of snakebite care in West Africa: perspectives from Nigeria

  2013cited by this paper
• Improving antivenom availability and accessibility: science, technology, and beyond.

  2012cited by this paper
• Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases.

  2011cited by this paper
• Randomised Controlled Double-Blind Non-Inferiority Trial of Two Antivenoms for Saw-Scaled or Carpet Viper (Echis ocellatus) Envenoming in Nigeria

  2010influential reference
• Snakebite envenoming from a global perspective: Towards an integrated approach.

  2010cited by this paper
• Hydroxamates: relationships between structure and plasma stability.

  2009cited by this paper
• Snakebite in Africa: Current Situation and Urgent Needs

  2009influential reference
• Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus.

  2009cited by this paper
• Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom.

  2008cited by this paper
• Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.

  2007cited by this paper
• Trends in snakebite envenomation therapy: scientific, technological and public health considerations.

  2007cited by this paper
• Purification and Characterization

  2006cited by this paper
• Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases.

  2005cited by this paper
• Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies.

  2005influential reference
• The intriguing world of prothrombin activators from snake venom.

  2005cited by this paper
• Medicinal plants with inhibitory properties against snake venoms.

  2005cited by this paper
• Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage.

  2005cited by this paper
• Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin.

  2005cited by this paper
• A novel P-I class metalloproteinase with broad substrate-cleaving activity, agkislysin, from Agkistrodon acutus venom.

  2004cited by this paper
• Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A(2).

  2003cited by this paper
• Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom.

  2003cited by this paper
• The purification and partial characterisation of two novel metalloproteinases from the venom of the West African carpet viper, Echis ocellatus.

  2003cited by this paper
• Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA.

  2000cited by this paper
• Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper.

  2000cited by this paper
• Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.

  1998cited by this paper
• Matrix metalloproteinase inhibitors in arthritis.

  1998cited by this paper
• Purification and characterization of a Ca2+ -dependent prothrombin activator, multactivase, from the venom of Echis multisquamatus.

  1997cited by this paper
• Isolation and Characterization of Carinactivase, a Novel Prothrombin Activator in Echis carinatus Venom with a Unique Catalytic Mechanism (*)

  1996cited by this paper
• cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom.

  1995cited by this paper
• Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc‐binding environments (HEXXHXXGXXH and Met‐turn) and topologies and should be grouped into a common family, the ‘metzincins’

  1993cited by this paper
• Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom.

  1989cited by this paper
• Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom.

  1985cited by this paper
• A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity.

  1984cited by this paper
• Development of simple standard assay procedures for the characterization of snake venom.

  1983influential reference
• [Myonecrosis, hemorrhage and edema induced by bothrops asper venom in white mice (author's transl)].

  1980cited by this paper
• Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco

  1980cited by this paper
• Prothrombin activation induced by Ecarin - a prothrombin converting enzyme from Echis carinatus venom.

  1975influential reference
• Bites by the Saw-scaled or Carpet Viper (Echis carinatus): Trial of Two Specific Antivenoms

  1974cited by this paper
• Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom.

  1960cited by this paper

• Venom variation and the future of antivenom design: integrating population venomics, evolutionary toxinology, and precision therapeutics

  2026cites this paper
• Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors

  2025cites this paper
• Dual Proteomics Strategies to Dissect and Quantify the Components of Nine Medically Important African Snake Venoms

  2025cites this paper
• Feasibility study: Varespladib protects CD-1 mice from lethal doses of whole bee (Apis mellifera) venom

  2025cites this paper
• Envenimation ophidienne : le retour des antidotes ?

  2025cites this paper
• Antivenoms, recombinant antibodies, inhibitors, and the future of snakebite envenoming therapy.

  2025cites this paper
• Differential Effects of Marimastat and Prinomastat on the Metalloprotease Activity of Various Snake Venoms

  2025cites this paper
• In vitro inhibition of snake venom toxins by varespladib, marimastat, nafamostat and dimercaprol.

  2025cites this paper
• Properties and Pharmacology of Scorpion Toxins and Their Biotechnological Potential in Agriculture and Medicine

  2025cites this paper
• Inhibition of proteolytic activity of Bothrops alternatus venom by two small molecules and docking analysis against a snake venom metalloproteinase.

  2025cites this paper
• Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani

  2025cites this paper
• Preclinical evaluation of small molecule inhibitors as early intervention therapeutics against Russell’s viper envenoming in India

  2025cites this paper
• Effects of toxin metalloproteinases from jellyfish Nemopilema nomurai nematocyst on the dermal toxicity and potential treatment of jellyfish dermatitis.

  2024cites this paper
• Assessing the Interactions between Snake Venom Metalloproteinases and Hydroxamate Inhibitors Using Kinetic and ITC Assays, Molecular Dynamics Simulations and MM/PBSA-Based Scoring Functions

  2024cites this paper
• Identification of antigenic proteins from the venom of Malaysian snakes using immunoprecipitation assay and tandem mass spectrometry (LC-MS/MS)

  2024cites this paper
• Enhancing Snakebite Management: The Role of Small Molecule Therapeutics in Complementing Antivenom Strategies.

  2024cites this paper
• Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies

  2024cites this paper
• Progress and Challenges in the Field of Snakebite Envenoming Therapeutics.

  2024cites this paper
• Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib

  2024cites this paper
• Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies

  2024cites this paper
• Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers

  2024cites this paper
• Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform

  2024cites this paper
• Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors

  2024cites this paper
• Dermonecrosis caused by spitting cobra snakebite is the result of toxin potentiation and is prevented by the repurposed drug varespladib

  2023cites this paper
• Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies

  2023cites this paper
• Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling

  2023cites this paper
• Oral and IV Varespladib Rescue Experiments in Juvenile Pigs with Weakness Induced by Australian and Papuan Oxyuranus scutellatus Venoms

  2023cites this paper
• Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming

  2023cites this paper
• Dermonecrosis caused by spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib

  2023cites this paper
• A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib

  2022cites this paper
• Snake Envenomation.

  2022cites this paper
• In vitro and in vivo venom-inhibition assays identify metalloproteinase-inhibiting drugs as potential treatments for snakebite envenoming by Dispholidus typus

  2022cites this paper
• In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

  2022cites this paper
• Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms

  2022cites this paper
• Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Bitis spp. and Echis spp. African snakes

  2022cites this paper
• Bibliometric Analysis of Literature in Snake Venom-Related Research Worldwide (1933–2022)

  2022cites this paper
• A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation

  2022cites this paper
• The puzzle of proteolytic effects in hemorrhage induced by Viperidae snake venom metalloproteinases

  2022cites this paper
• Assessment of snakebite burdens, clinical features of envenomation, and strategies to improve snakebite management in Vietnam.

  2021cites this paper
• Clinical implications of differential procoagulant toxicity of the Palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors.

  2021cites this paper
• In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles

  2021cites this paper
• Small Molecule Drug Discovery for Neglected Tropical Snakebite.

  2021cites this paper
• Self-assembled nanocarriers as biotechnology approach to antivenom immunotherapy

  2021cites this paper
• A rational in silico approach to identify inhibitors of Batroxrhagin from Bothrops atrox

  2021cites this paper
• A Biomimetic of Endogenous Tissue Inhibitors of Metalloproteinases: Inhibition Mechanism and Contribution of Composition, Polymer Size, and Shape to the Inhibitory Effect.

  2021cites this paper
• The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming

  2021cites this paper
• A SYSTEMATIC REVIEW ON SNAKE VENOM AND ITS THERAPEUTIC IMPLICATION

  2021cites this paper
• Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite.

  2021cites this paper
• Prospects and Challenges of Developing Plant‐Derived Snake Antivenin Natural Products: A Focus on West Africa

  2021cites this paper
• Varespladib (LY315920) rescued mice from fatal neurotoxicity caused by venoms of five major Asiatic kraits (Bungarus spp.) in an experimental envenoming and rescue model.

  2021cites this paper
• A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

  2020cites this paper
• Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation.

  2020cites this paper
• Snake Antivenom: challenges and alternate approaches.

  2020cites this paper
• Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic Viperinae Snake Venom Toxins

  2020cites this paper
• Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases

  2020cites this paper
• A therapeutic combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite

  2020cites this paper
• Snake Envenomation

  2020cites this paper
• Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite

  2020cites this paper
• Natural Inhibitors of Snake Venom Metalloproteinases

  2020cites this paper
• Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms

  2020cites this paper
• Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2

  2019cites this paper
• Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming

  2019cites this paper
• Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Local Tissue Damage Induced by a Type P-I Snake Venom Metalloproteinase

  2019cites this paper
• Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite

  2019cites this paper
• History of Envenoming Therapy and Current Perspectives

  2019cites this paper
• The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites

  2019cites this paper
• Multifunctional Toxins in Snake Venoms and Therapeutic Implications: From Pain to Hemorrhage and Necrosis

  2019cites this paper
• Engineering and design considerations for next-generation snakebite antivenoms.

  2019cites this paper
• Recent Advances in Next Generation Snakebite Antivenoms

  2018cites this paper
• The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms

  2018cites this paper
• Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †

  2018cites this paper
• Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of Micrurus fulvius (Eastern Coral Snake) Venom

  2018cites this paper
• Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom

  2018cites this paper
• Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite

  2018cites this paper
• Anti-Ophidian Properties Of Herbal Medicinal Plants: Could It Be A Remedy For Snake Bite Envenomation?

  2018cites this paper
• Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies

  2018cites this paper
• Toxin-centric development approach for next-generation antivenoms.

  2018cites this paper
• Advances in Clinical Research of Matrix Metalloproteinase Inhibitors as Anticancer Agents

  2018cites this paper
• An improved technique for the assessment of venom‐induced haemorrhage in a murine model

  2017cites this paper